Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
The Lancet. Haematology|March 5, 2021
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trialFabian Frontzek, Marita Ziepert, Maike Nickelsen, et al.
Blood|November 19, 2011
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Kayser, Manuela Zucknick, Konstanze Döhner, et al.
The Lancet. Haematology|February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
The Journal of Experimental Medicine|April 20, 2005
Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.
Blood|December 22, 2011
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcomeFrank G Rücker, Richard F Schlenk, Lars Bullinger, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Blood|October 2, 2014
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantationRichard F Schlenk, Sabine Kayser, Lars Bullinger, et al.
Blood|May 7, 2014
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patientsMichela Tassara, Konstanze Döhner, Peter Brossart, et al.
Blood|July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPARichard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
Pageof 8